DSM : Sees 2017 CAPEX to be between 500 million euros ($528 million) and 550 million euros - conference call . Says prices in the beginning of 2017 expected to be approximately equivalent to prices in the beginning of 2016 - conference call . Says expecting continued growth for 2017 including in the animal nutrition business - conference call . Says focusing on operational performance for 2016/2017 - conference call . Says does not anticipate higher prices at this moment - conference call . Says market conditions remain pretty solid - conference call . Expects to grow on nutrition business of about 3 to 4 percent for 2017 - conference call . Says bird flu situation expected to have no major impact on their business - conference call Further company coverage: [DSMN.AS] ($1 = 0.9474 euros) (Gdynia Newsroom) ((firstname.lastname@example.org; +48 58 772 0920;)).